Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications
Author(s) -
Veerendra Sandur,
M. Murugesh,
Vaibhav S Banait,
PM Rathi,
SJ Bhatia,
JM Joshi,
Arvind Kate
Publication year - 2014
Publication title -
journal of postgraduate medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.405
H-Index - 52
eISSN - 0972-2823
pISSN - 0022-3859
DOI - 10.4103/0022-3859.138754
Subject(s) - medicine , asthma , gerd , omeprazole , reflux , proton pump inhibitor , pulmonary function testing , gastroenterology , disease
The hypothesis that GER can trigger or exacerbate asthma is supported by several clinical trials that have shown amelioration in asthma symptoms and/or an improvement in pulmonary function after antireflux therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom